Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.24M Buy
6,370
+379
+6% +$135K 0.28% 86
2025
Q4
$1.96M Sell
5,991
-1,182
-16% -$375K 0.26% 93
2025
Q3
$2.02M Sell
7,173
-85
-1% -$24.7K 0.24% 112
2025
Q2
$2.03M Buy
7,258
+230
+3% +$65.2K 0.25% 111
2025
Q1
$2.16M Sell
7,028
-76
-1% -$22.4K 0.26% 106
2024
Q4
$1.85M Buy
7,104
+1,791
+34% +$531K 0.22% 122
2024
Q3
$1.71M Sell
5,313
-152
-3% -$49.7K 0.24% 121
2024
Q2
$1.71M Buy
5,465
+515
+10% +$151K 0.25% 115
2024
Q1
$1.41M Buy
4,950
+1,271
+35% +$372K 0.23% 122
2023
Q4
$1.06M Buy
3,679
+659
+22% +$180K 0.21% 125
2023
Q3
$812K Buy
3,020
+283
+10% +$70.6K 0.2% 127
2023
Q2
$608K Buy
2,737
+251
+10% +$58.2K 0.15% 162
2023
Q1
$601K Sell
2,486
-174
-7% -$42.7K 0.21% 136
2022
Q4
$691K Buy
2,660
+260
+11% +$69.7K 0.19% 123
2022
Q3
$541K Buy
2,400
+231
+11% +$56K 0.22% 115
2022
Q2
$528K Buy
+2,169
New +$532K 0.22% 115

Other funds holding AMGN

Naviter Wealth's AMGN Position: Q1 2026 in Review

Naviter Wealth increased its Amgen (AMGN) stake by 6.3% in Q1 2026, buying an estimated $135K and bringing the position to 6,370 shares worth $2.24M. The position accounts for 0.28% of the portfolio, ranked #86.

Naviter Wealth first reported a position in AMGN in Q2 2022 and has held it in 16 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Naviter Wealth held 6,370 shares of Amgen worth $2.24M as of Q1 2026.
  • Naviter Wealth bought 379 Amgen shares in Q1 2026, an estimated $135K.
  • Amgen made up 0.28% of Naviter Wealth's portfolio in Q1 2026, its #86 holding.
  • Naviter Wealth first reported a position in Amgen in Q2 2022 and has held it in 16 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Naviter Wealth's 13F filing for Q1 2026, filed 10 Apr 2026.